Background: Magnesium is a vital element in the body involved in biochemical and physiological processes. Magnesium deficiency can lead to serious consequences including cardiac, neurological, muscular disorders, and other clinical manifestations.
Nastaran Nazarzade +5 more
doaj +1 more source
Current Understandings on Magnesium Deficiency and Future Outlooks for Sustainable Agriculture. [PDF]
Chaudhry AH +4 more
europepmc +1 more source
#411 Magnesium deficiency abrogates the activation of Insulin-like growth factor-1 signaling pathway in the kidney induced by DPP4 inhibitor [PDF]
Takamasa Iwakura +2 more
openalex +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
[SARS-CoV-2 infection promoted by magnesium deficiency in the geriatric patient]. [PDF]
Moltó Balado P, Docampo Sierra S.
europepmc +1 more source
MYOPATHY IN EXPERIMENTAL MAGNESIUM DEFICIENCY* [PDF]
H. Alexander Heggtveit
openalex +1 more source
Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss
ABSTRACT Objective To describe the use of central stimulants and amantadine for fatigue in MS and evaluate a potential association with reduced work loss in people with MS. Methods We conducted a nationwide, matched, register‐based cohort study in Sweden (2006 to 2023) using national registers with prospective data collection.
Simon Englund +3 more
wiley +1 more source
Magnesium Deficiency Alters Expression of Genes Critical for Muscle Magnesium Homeostasis and Physiology in Mice. [PDF]
Bayle D +9 more
europepmc +1 more source
THE EFFECTS OF MAGNESIUM DEFICIENCY ON KETAMINE SLEEPING TIMES IN THE RAT
Barry Douglas, Rose Dagirmanjian
openalex +1 more source
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo +9 more
wiley +1 more source

